C81.45
Lymphocyte-rich Hodgkin lymphoma, lymph nodes of inguinal region and lower limb
Clinical Classification Guidelines
Medical Intelligence & Overview
Lymphocyte-rich Hodgkin lymphoma is a specific subtype of Hodgkin lymphoma characterized by the presence of abundant lymphocytes within affected lymph nodes. When it involves the lymph nodes in the inguinal region (groin area) and the lower limbs, it can cause noticeable swellings and other symptoms. This condition is part of a broader category of lymphomas, which are cancers originating in the lymphatic system, a crucial part of the immune system. Understanding this condition helps in recognizing its features and the importance of medical evaluation for accurate diagnosis and management.
Causes & Symptoms
Clinical Causes: Exact cause of Hodgkin lymphoma remains unknown; however, it is believed to involve genetic factors and immune system responses. Infection with Epstein-Barr virus (EBV) has been associated with increased risk. Family history of lymphoma may increase susceptibility. Immunosuppression, often seen in individuals with previous organ transplants or HIV infection, can elevate risk.
Key Symptoms: Painless swelling or lumps in the inguinal region or in the lower limbs. Persistent fatigue and weakness. Unexplained weight loss over a short period. Fever that may come and go. Night sweats, often drenching. Itching skin (pruritus). Swelling or discomfort in the abdomen if lymph nodes or organs enlarge. Rarely, symptoms related to nerve compression if lymph nodes press on nearby structures.
Diagnostic & Treatment
Diagnosis Path: Physical examination to assess lymph node swelling and related symptoms. Biopsy of affected lymph nodes to identify Hodgkin Reed-Sternberg cells characteristic of Hodgkin lymphoma. Imaging tests such as PET scans, CT scans, or MRI to determine the extent of disease spread. Blood tests to evaluate overall health and organ function. Bone marrow biopsy if systemic involvement is suspected. Immunophenotyping and other laboratory tests to confirm the subtype of Hodgkin lymphoma.
Treatment Protocols: Chemotherapy, often the main treatment; regimens are tailored based on disease stage and patient health. Radiation therapy, especially for localized disease or residual lymph nodes after chemotherapy. Targeted therapy or immunotherapy may be options depending on specific circumstances. Supportive care including medications to manage symptoms and side effects, and monitoring for treatment response. Follow-up care involves regular scans and check-ups to detect possible recurrence and manage long-term effects.
Clinical Advice & FAQs
Billing Guidance
Is C81.45 a billable ICD-10 code?
Yes, C81.45 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C81.45?
Clinical documentation must specify the nature of Lymphocyte-rich Hodgkin lymphoma, lymph nodes of inguinal region and lower limb and any associated comorbidities for accurate reporting.
Cite this Clinical Reference